Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04363515 · ClinicalTrials.gov registry record · NA
Pilot Social Support Counseling Intervention for Kidney Transplant Candidates
A NA study, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04363515: Completed NA study, sponsored by Hennepin Healthcare Research Institute.
NCT04363515 is a NA study that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04363515, a NA study, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Feasibility pilot social support counseling intervention for kidney transplant candidates
Primary Outcome
Question key (true/false, multiple choice) 1. A patient on dialysis has the same level of kidney functioning as a patient with a transplanted kidney. 2. In general, patients can live at least 5 years longer with a kidney transplant than if they stayed on dialysis. 3. In general, most people on dialysis are happier with the quality of their lives than people with transplants. 4. Patients have better health outcomes if they receive a transplant before starting dialysis. 5. If a patient waits long
Interventions
- BEHAVIORAL Social support network counseling intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT04363515 record still lists
NCT04363515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Social support network counseling intervention is the first listed.
NCT04363515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04363515 about?
NCT04363515 is a clinical study titled "Pilot Social Support Counseling Intervention for Kidney Transplant Candidates". Feasibility pilot social support counseling intervention for kidney transplant candidates
What is the current status of trial NCT04363515?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2020-08-01. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT04363515?
The interventions under investigation include: Social support network counseling intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04363515?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04363515's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI